Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

被引：0
|
作者：
Mandorfer, M. [1 ]
Schwabl, P. [1 ]
Bucsics, T. [1 ]
Paternostro, R. [1 ]
Pomej, K. [1 ]
Thaler, J. [2 ]
Ay, C. [2 ]
Quehenberger, P. [3 ]
Trauner, M. [1 ]
Peck-Radosavljevic, M. [1 ,4 ]
Reiberger, T. [1 ]
Ferlitsch, A. [1 ]
机构：
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria
[3] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[4] Klinikum Klagenfurt Woerthersee, Dept Gastroenterol & Hepatol Endocrinol & Nephrol, Klagenfurt Am Worthersee, Austria
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31093-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-015
引用
收藏
页码：S373 / S374
页数：2
相关论文
共 50 条
  • [1] VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION
    La Mura, V.
    Reverter, J. C.
    Flores-Arroyo, A.
    Hernandez-Guerra, M.
    Abraldes, J. G.
    Garcia-Pagan, J. C.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S75 - S76
  • [2] Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity
    Mandorfer, M.
    Schwabl, P.
    Paternostro, R.
    Pomej, K.
    Bauer, D.
    Thaler, J.
    Ay, C.
    Quehenberger, P.
    Fritzer-Szekeres, M.
    Peck-Radosavljevic, M.
    Trauner, M.
    Reiberger, T.
    Ferlitsch, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 980 - 988
  • [3] VON WILLEBRAND FACTOR PREDICTS RESPONSE TO MEDICAL THERAPY OF PORTAL HYPERTENSION
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S80 - S80
  • [4] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Georgios N Kalambokis
    Gerasimos Baltayiannis
    Dimitrios Christodoulou
    [J]. World Journal of Gastroenterology, 2016, (19) : 4786 - 4788
  • [5] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Kalambokis, Georgios N.
    Baltayiannis, Gerasimos
    Christodoulou, Dimitrios
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (19) : 4786 - 4788
  • [6] Von Willebrand factor predicts clinically significant portal hypertension in patients with liver cirrhosis
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S114 - S115
  • [7] PORTAL HYPERTENSIVE BLEEDING INDEPENDENTLY PREDICTS MORTALITY IN PATIENTS HOSPITALIZED FOR ALCOHOLIC HEPATITIS
    Kim, W.
    Kim, S. H.
    Kim, H. Y.
    Jung, Y. J.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S763 - S764
  • [8] The role of portal pressure in the severity of bleeding in portal hypertensive rats
    Castañeda, B
    Debernardi-Venon, W
    Bandi, JC
    Andreu, V
    Pérez-del-Pulgar, S
    Moitinho, E
    Pizcueta, P
    Bosch, J
    [J]. HEPATOLOGY, 2000, 31 (03) : 581 - 586
  • [9] Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis
    Langholm, Lasse L.
    Manon-Jensen, Tina
    Karsdal, Morten A.
    Bendtsen, Flemming
    Leeming, Diana J.
    Moller, Soren
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1040 - 1048
  • [10] Von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension
    Kawut, SM
    Horn, EM
    Berekashvili, KK
    Widlitz, AC
    Rosenzweig, EB
    Barst, RJ
    [J]. CHEST, 2005, 128 (04) : 2355 - 2362
12345